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Ltd. This is an open access article undAbstract Objective: To elucidate the progression of angioedema of the head and neck with
routine management and to assess the utility of serial physical exams and fiberoptic laryngos-
copy in its management.
Methods: This study was a prospective observational research. From 2013 to 2014, a prospec-
tive observational study was conducted at a tertiary referral center. Forty patient were ap-
proached, 7 refused, 33 (18e90 years old) were enrolled. Patients presented with
angioedema involving the head and neck over a 12 month period were asked to participate
in the study. Physical examination and fiberoptic laryngoscopy were performed at presentation
and then repeated at least 1 h later.
Results: Thirty-three patients with head and neck angioedema from any cause were enrolled
(mean age 58, range 23e89 years). The upper lip was the most commonly involved site (58%).
On reevaluation, 82% of patients reported subjective improvement in symptoms. Thethe American Laryngological Association 2015 meeting, Boston, MA.
of Otolaryngology-Head & Neck Surgery, Temple University School of Medicine, 3400 North Broad
, PA 19140, USA. Tel.: þ1 215 707 3665; fax: þ1 215 707 7523.
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8 G. Linkov et al.association between subjective improvement and the physical exam, including fiberoptic
laryngoscopy findings, was statistically significant (P < 0.001).
Conclusion: In stable patients with angioedema of any head and neck subsite, self-reported
symptoms are associated with clinical stability or improvement as assessed by physical signs
and fiberoptic laryngoscopy. Patients’ symptoms may be an appropriate surrogate to monitor
clinical status without the need for routine serial physical examinations or fiberoptic laryngos-
copy, though further study is needed.
Copyright ª 2016 Chinese Medical Association. Production and hosting by Elsevier B.V. on
behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Angioedema (AE) is defined as a self-limited, localized
swelling that often occurs in the head and neck. It most
commonly affects the face, lips, palate, and tongue, with
laryngeal involvement occurring less frequently. It results
from increased permeability of the vasculature supplying
the subcutaneous, submucosal, and deep dermal tissues.
AE can occur in both sporadic and hereditary forms. AE of
the head and neck is potentially life-threatening, as it may
lead to airway compromise.
Airway management is the single most important aspect
of acute therapy, regardless of the etiology of AE.1,2 The
otolaryngologist is frequently consulted to evaluate the
patient and to determine the need for acute airway inter-
vention. Though serial physical examinations, including
fiberoptic laryngoscopy, are routinely performed to deter-
mine the progression of disease, the utility of this approach
has not been adequately studied.
To date, there have been few studies investigating the
appropriate management of patients with AE.3e10 Most are
retrospective reviews that report the authors’ clinical
experience with AE and subsequently make recommenda-
tions regarding best practices. Only one study has pro-
spectively examined angioedema triggered by angiotensin-
converting enzyme inhibitors (ACEi), however, the authors
did not correlate symptomatology with findings on serial
physical examinations.4
The goal of this study was to elucidate the progression of
angioedema of the head and neck with routine medical
management and to assess the utility of serial physical
exams, including the use of fiberoptic laryngoscopy.Materials and methods
After institutional review board approval was obtained, all
patients presenting to the Emergency Department (ED) with
angioedema involving the head and/or neck between
December 2013 and December 2014 were asked to partici-
pate in this prospective, observational study. Informed
consent was obtained on the day of discharge for all pa-
tients in this study, including those discharged from the ED
on the day of presentation. Patients who were medically
unstable or required emergent intubation were excluded.
Patients received standard and similar medical manage-
ment for angioedema with the use of systemic intravenous
H1 and H2 blockers and steroids.All patients underwent complete head and neck exami-
nation and fiberoptic laryngoscopy at presentation by the
ED physicians and/or the Otolaryngology physicians. When
the Otolaryngology service was consulted, their findings
were used for the study. Patients who were admitted for
observation and did not require airway intervention un-
derwent a repeat head and neck examination by the
Otolaryngology service, including fiberoptic laryngoscopy in
most cases, at least 1 h later. On reexamination, patients
were asked to report subjective improvement by answering
yes or no to the question: “do you feel better?” Also on
reexamination, evaluating physicians determined a global
clinical assessment as improved, worse, or same.
The patients’ demographics, past medical, social and
family histories, symptoms and signs at presentation, and at
reevaluation, were recorded by ED physicians and/or
Otolaryngology physicians on standardized forms specifically
made for this study. The following anatomic sites were spe-
cifically assessed for involvement on examination: the face,
neck, upper lip, lower lip, anterior tongue, floor of mouth,
soft palate, base of tongue, supraglottis, and glottis. Each
site was recorded as being involved or not involved and then
an overall subjective assessment of degree of involvement
was recorded as mild, moderate, or severe.
Only ‘water bag’ edema, typically associated with acute
angioedema of the head and neck, was considered positive
for site involvement. The criteria for intubation were based
on an overall clinical state. Endoscopic findings that were
deemed concerning and likely to warrant airway protection
were an inability to see the glottic opening secondary to
edema or a documented worsening of edema on repeat
examination despite medical management.
A univariate analysis of involved anatomic site and the
need for intubation, as well as self-reported symptom
improvement (feeling better versus not feeling better) and
physical examination (improved/same versus worsened)
was carried out using Fisher’s exact test. Significance was
defined a priori as P < 0.05. All statistical analysis was
performed using SPSS version 19.0 (SPSS, Chicago, IL).Results
Thirty-three patients with head and neck angioedema (AE)
were enrolled. The mean age was 58 years (range 23e89
years). Seventy three percent of patients were female.
Ninety one percent were African American. Hypertension
was present in 85% of patients. An angiotensin-converting
enzyme inhibitor (ACEi) was identified as the etiology of the
Table 1 Patient characteristics.
Variable n (%)
# Of patients 33
Age 58 yrs (23e89)
Sex
Female 24 (73)
Male 9 (27)
Ethnicity
AA 30 (91)
Hispanic 1 (3)
Caucasian 2 (6)
DM 8 (24)
HTN 28 (85)
CAD 6 (18)
Asthma 6 (18)
Facial trauma 0
Seasonal allergy 3 (9)
Food allergy 5 (15)
Drug rash 1 (3)
Atopic dermatitis 0
Family history of AE 3 (9)
Tobacco 10 (30)
Alcohol 9 (27)
Prior episodes of AE 16 (49)
AA: African American; DM: Diabetes mellitus; HTN: Hyperten-
sion; CAD: Coronary artery disease; AE: Angioedema.
Table 2 Initial presentation: symptoms.
Variable n (%)
Otolaryngology consult 29 (88)
Time since symptoms started (min) 583 (20e2880)
Etiology
ACEi 25 (76)
Allergy 5 (15)
Other 3 (9)
When ACEi initiated
<1 yr 6 (18)
1e5 yr 8 (24)
>5 yr 8 (24)
Dyspnea 3 (9)
Hoarseness 4 (12)
Odynophagia 3 (9)
Dysphagia 7 (21)
Globus sensation 5 (15)
Cough 2 (6)
Abdominal pain 1 (3)
FOL by ER 17 (51)
ACEi: Angiotensin-converting enzyme inhibitor; FOL: Fiberoptic
laryngoscopy.
Fig. 1 Still frame image of a fiberoptic laryngoscopy exami-
nation of a patient with right-sided supraglottic edema (area
encircled in black). The right true vocal fold is partially
obscured by the supraglottic edema. The left arytenoid (A) and
left false vocal fold (F) are marked. Of note, this patient
improved clinically and on repeat examination and did not
require intubation.
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had been on the medication for more than one year.
Sixteen patients (48%) had a prior episode of AE. Additional
patient characteristics are summarized in Table 1.
At presentation, the mean time since onset of symptoms
was 583 min (range 20e2880 min). The most common
symptom was dysphagia in 21% of patients. Four patients
presented with hoarseness (12%); none had stridor or res-
piratory distress. Additional patient symptoms at presen-
tation are summarized in Table 2.
The upper lip was the most commonly involved site (58%)
on examination, followed by the lower lip (45%), anterior
tongue (30%), face (21%), soft palate (18%), supraglottis
(18%), floor of mouth (15%), base of tongue (12%), and neck
(9%). No glottic edema was observed. More than one site
was involved in 76% of patients. The overall edema severity
on initial presentation was mild in 55% of patients (scale of
mild, moderate, or severe). An example of a patient, from
this series, with supraglottic edema can be seen in Fig. 1.
All patients received intravenous dexamethasone or
methylprednisolone, diphenhydramine, and famotidine in
the ED and during their hospitalization. The Otolaryngology
service was asked by the ED to evaluate 88% of patients.
The remainder of the patients were evaluated only by the
ED and discharged home on the same day. The initial
fiberoptic laryngoscopy was performed by an Emergency
Department physician in 51% of all patients in the study
(including all of the patients who were discharged without
Otolaryngology consultation), and was routinely performed
on all patients seen by the Otolaryngology service. Repeat
fiberoptic laryngoscopy was performed on 26 patients (79%)
of all patients in the study. Seven patients underwent onlyone laryngoscopy: six were discharged home from the ED
and one was intubated due to worsening symptoms.
Four patients (12%) were intubated. One patient had
only anterior tongue edema. Another patient had anterior
tongue, neck, and supraglottic edema. A third patient had
Table 3 Initial presentation: exam.
Variable n (%) P-value
(for requiring intubation)
Stridor 0
Hoarseness 3 (9)
Respiratory distress 0
Face 7 (21) 0.555
Neck 3 (9) 0.330
Upper lip 19 (58) 0.288
Lower lip 15 (45) 0.607
Anterior tongue 10 (30) 0.073
FOM 5 (15) 0.500
Soft palate 6 (18) 0.142
BOT 4 (12) 0.420
Supraglottis 6 (18) 0.142
Glottis 0 N/A
Severity
Mild 18 (55)
Moderate 11 (33)
Severe 4 (12)
CAT initiated 1 (3)
Total intubated in study 4 (12)
FOM: Floor of mouth; BOT: Base of tongue; CAT: Critical airway
team; N/A: Not available.
Table 4 Reevaluation.
Variable n (%) P-value
(for clinical status)
Time since first
evaluation (min)
307 (60e1200)
“Do you feel better?”
Yes 27 (82) P < 0.001
No 6 (18)
Dyspnea 1 (3)
Hoarseness 1 (3)
Odynophagia 1 (3)
Dysphagia 2 (6)
Globus sensation 4 (12)
Stridor 0
Respiratory distress 0
Sites still involved
Face 2 (6)
Neck 1 (3)
Upper lip 11 (33)
Lower lip 7 (21)
Anterior tongue 4 (12)
FOM 2 (6)
Soft palate 4 (12)
BOT 4 (12)
Supraglottis 5 (15)
Glottis 0
Clinical status
Same/Improved 28 (85)
Worse 5 (15)
Intubated 4 (12)
Disposition
Admit 26 (79)
Discharge 6 (18)
Left AMA 1 (3)
Days in hospital
if admitted
3 (2e6)
FOM: Floor of mouth; BOT: Base of tongue; AMA: Against med-
ical advice.
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supraglottic edema. A fourth patient had soft palate and
supraglottic edema. No anatomic site had a statistical as-
sociation with intubation (Table 3).
A repeat evaluation was performed (with or without
laryngoscopy) at amean timeof 307min (range 60e1200min)
after the initial examination. On reevaluation, 82% of pa-
tients reported subjective improvement in symptoms
(answered “yes” to the question “do you feel better?”) The
association between symptom improvement and physical
examination findings, including fiberoptic laryngoscopy, was
statistically significant (P < 0.001). A reduction in the num-
ber of patientswith edemaat all involved siteswas observed;
edema was now present in: upper lip (33%), lower lip (21%),
supraglottis (15%), anterior tongue (12%), soft palate (12%),
base of tongue (12%), floor ofmouth (6%), face (6%), and neck
(3%). Seventy-nine percent of patients were admitted to the
hospital for further medical management, 18% were dis-
charged from the ED, and one patient left against medical
advice. For those patients who were admitted, the average
length of stay was 3 days (range 2e6 days). No deaths
occurred in the study population. Reevaluation data is sum-
marized in Table 4.Discussion
Angioedema involving the head and neck remains a com-
mon reason for emergent Otolaryngology consultation by
the Emergency Department. The task assigned is to deter-
mine which patients require immediate airway control and
to predict which patients may progress to require airway
intervention at a later point. We aimed to determine the
progression of AE with medical treatment in the ED and thepredictive roles of patients’ symptoms, physical examina-
tion and fiberoptic laryngoscopy in answering these ques-
tions in a prospective fashion.
Angiotensin-converting enzyme inhibitors remain the
main cause of angioedema of the head and neck. Our study
found a higher percentage of ACEi-induced AE (76%)
compared to others, where it was as low as 30% of all AE
cases.9 This may be related to their use as renal protective
agents in diabetic patients, which are ubiquitous in our
study population.10 It is concerning that such a high per-
centage of patients (49%) continued to be on an ACEi
despite having had prior episodes of angioedema related to
it. An editorial in 2008 highlighted the hope that physical
decision support systems in electronic medical records may
help prevent this exact type of scenario.11
The most commonly affected sites are the lips and
tongue. In a large retrospective chart review which
assessed 228 patients with ACEi-induced AE, the lips were
affected in 54% of cases and the tongue in 40% of cases.5 In
our series, we had similar findings with the upper lip spe-
cifically being the most commonly affected site in 58% of
Serial exams in angioedema 11cases. Of note, there were no patients with glottic edema
in our series. This is likely related to the exclusion of pa-
tients who required immediate intubation.
In our study, the anterior tongue was the only anatomic
site to show a trend toward a statistically significant rela-
tionship with intubation (P Z 0.073). Similarly, McCormick
et al.8 in a retrospective review found an airway inter-
vention rate of 16%, which was significantly increased with
involvement of the anterior tongue, base of tongue, and
larynx. Only one prospective observational study exists on
the topic of head and/or neck angioedema as it relates to
airway management.12 Forty patients with ACEi-induced AE
were included, of which 6 (15%) required intubation. The
only physical exam finding to be statistically correlated
with requiring intubation was massive tongue edema. The
patients’ symptom progression as it related to objective
findings, however, was not evaluated.
Although several authors have previously investigated
airway management in patients with angioedema, the role
of serial physical examinations in this patient group is not
well elucidated. Ishoo et al.4 sought to predict the risk of
airway compromise in AE by retrospectively reviewing 93
episodes in 80 patients over a 10-year period. Intubation or
tracheotomy was necessary in 9 cases (9.7%), all involving
the tongue and/or larynx, which were subsequently defined
as the high-risk groups. No correlation between symptoms
and findings on serial physical examinations was performed.
Bentsianov et al.3 correlated symptoms and fiberoptic
laryngoscopy findings on initial examination with the need for
urgent airway intervention. In this retrospective review of 74
patients, 14 patients (20%) required immediate airway inter-
vention. No patient with a normal fiberoptic exam required
immediate or delayed airway intervention. However, only 32
patients (43%) underwent fiberoptic laryngoscopy. Again, no
comment is made on the progression of symptoms and its
association with serial physical examinations.
Finally, a recent retrospective review of ACEi related AE
from our institution found that 6 patients (6.8%) were
intubated after serial fiberoptic laryngoscopy revealed
progression of angioedema; 5 of these patients were intu-
bated after their second laryngoscopy and 1 was intubated
after the third laryngoscopy.10 No association of symptoms
and physical findings on serial examinations was made given
the retrospective nature.
In the present study, only 4 patients (12%) required
intubation, 2 had severe anterior tongue edema (one
without laryngeal edema and one with resolved laryngeal
edema), 1 progressed to involve the larynx, soft palate, and
base of tongue, and 1 presented initially with significant
laryngeal edema. Of note, the patient who had progressive
involvement on physical examination reported worsening of
symptoms on reevaluation. There was a statistically sig-
nificant association between patient symptoms and phys-
ical examination findings, including fiberoptic
laryngoscopy, for the entire group.
Our results suggest that patients’ symptoms can guide
clinical management and are well associated with findings
on serial physical examinations. Patients’ self-reported
impression of how they feel during the course of angioe-
dema treatment may be as effective as routinely per-
forming serial physical examinations, including fiberoptic
laryngoscopy, in guiding clinical management.One limitation of our study is the small sample size.
Additionally, our patient cohort was of relatively lower
clinical severity, as we excluded medically unstable pa-
tients who required emergent airway intervention prior to a
structured airway assessment. This may explain the lower
incidence of laryngeal findings at presentation in our pa-
tients. Finally, the timing of the repeat examination was
variable between 60 and 1200 min, which could serve as a
potential confounder.
Summary
1. Angioedema of the anterior tongue should raise concern
for potentially requiring airway intervention.
2. Angioedema not initially involving the larynx rarely
progresses to involve it.
3. Angioedema involving the larynx did not worsen with
treatment.
4. In stable patients with angioedema of any head and neck
subsite, self-reported symptoms are associated with
clinical stability or improvement as assessed by physical
signs and fiberoptic laryngoscopy.
5. Patients’ symptoms may be an appropriate surrogate to
monitor clinical status without the need for routine se-
rial physical examinations or fiberoptic laryngoscopy,
though further study is needed.Funding
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